Roth Capital Starts Hyperion Therapeutics (HPTX) at Buy
Tweet
Share
E-mailGet Alerts HPTX Hot Sheet
Price: $45.99 --0%
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Join SI Premium – FREE
Roth Capital initiated coverage on Hyperion Therapeutics (NASDAQ: HPTX) with a Buy rating and a price target of $34.00.
For an analyst ratings summary and ratings history on Hyperion Therapeutics click here. For more ratings news on Hyperion Therapeutics click here.
Shares of Hyperion Therapeutics closed at $24.30 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B.Riley Starts Weave Communications Inc (WEAV) at Buy
- Barclays Starts Centrus Energy Corp. (LEU) at Equalweight
- Macquarie Starts Sunway Construction (SCGB:MK) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
